about
Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration.Key Targets for Multi-Target Ligands Designed to Combat NeurodegenerationFUS Interacts with HSP60 to Promote Mitochondrial DamageMitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration.Agonism of the 5-hydroxytryptamine 1F receptor promotes mitochondrial biogenesis and recovery from acute kidney injuryEfavirenz induces neuronal autophagy and mitochondrial alterations.Association of mitochondrial DNA levels with frailty and all-cause mortality.Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALSInduction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E).Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Suppression of oxidative phosphorylation in mouse embryonic fibroblast cells deficient in apurinic/apyrimidinic endonuclease.Critical role of calpain in spinal cord degeneration in Parkinson's diseaseMitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.Making the brain glow: in vivo bioluminescence imaging to study neurodegeneration.Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders.A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress.Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.Sustained O-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism.5-HT1F receptor-mediated mitochondrial biogenesis for the treatment of Parkinson's disease.Intrauterine Reprogramming of the Polycystic Ovary Syndrome: Evidence from a Pilot Study of Cord Blood Global Methylation Analysis.Effect of a trans fatty acid-enriched diet on mitochondrial, inflammatory, and oxidative stress parameters in the cortex and hippocampus of Wistar rats.Short Overview.Carnosic Acid Suppresses the H2O2-Induced Mitochondria-Related Bioenergetics Disturbances and Redox Impairment in SH-SY5Y Cells: Role for Nrf2.Approaches for Identifying Novel Targets in Precision Medicine: Lessons from DNA Repair.Comparative Analysis of Mutant Huntingtin Binding Partners in Yeast Species.Mitochondrial Targeting in Neurodegeneration: A Heme PerspectiveNanometer ultrastructural brain damage following low intensity primary blast wave exposureThe Mitochondrion-lysosome Axis in Adaptive and Innate Immunity: Effect of Lupus Regulator Peptide P140 on Mitochondria Autophagy and NETosisColocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's DiseaseRegion-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease
P2860
Q27300826-5413155A-79AC-4797-A4DC-82398314F77DQ28077589-7FE0BFA4-CE06-4309-BD37-1AA349B2AAE5Q28547727-36CD22E9-23DB-43B7-BA81-B97D046AE1F9Q30600526-49F458EC-67FB-4BEA-A257-67073A91BED0Q33603263-47D6A368-4A3F-4F7A-BA01-4ABB1CA13A7CQ33943971-20D87409-6555-44BE-BA50-01BF692F22B6Q34360731-69F60650-3033-47BD-BF91-4AD4C5BB1E06Q35058501-38291696-0689-41DA-8F8B-18ACBA477EEBQ35891904-61297D07-40AC-4018-B7F2-52F30EF93500Q36167749-FA17967D-7196-433A-903A-B028AB518760Q36372732-2AB888AD-CB38-4200-B4F3-5934FB5C7A69Q36837710-26D97365-0F06-4995-85BD-E7E77EA023ABQ37384896-410E3CEA-3E2C-40DC-A795-A108428CF473Q37686261-53E6C769-9CA8-4CC8-A3A3-9B1F00303B59Q38034108-2652120A-DF93-417D-97B0-0B670171E974Q38063413-01754626-0B0A-4A2F-B8E9-2F1B05FA3C90Q38066606-681CF54C-3BA4-4564-815C-969F79109D84Q38239644-EBDDDD9E-1745-4661-993D-6449B5EA3D22Q38649157-7BA462CC-822A-42AF-B72F-39C8A81810ADQ38716156-A1C55ECD-3BA7-4771-A54C-CB6B3212B657Q38962796-046F16E7-FE48-487C-985E-78D885BA8BBAQ41173095-CF39815E-CC3E-49EF-8FC1-54C7F07552F8Q41846921-FB690653-C577-4182-A0D4-F037EC0F2431Q46331471-54ECB0EA-7498-405C-BB8C-76E86D68CC68Q47618763-EB576FAA-CBE1-4DD5-B28B-D5D75D9C7F62Q47657545-6C82EE2F-16BD-4DC0-84F3-D13846133FD2Q48347404-A9C8B17D-D396-4434-AF51-002DE33263B2Q51006837-3D3CABD2-574D-45D6-A58C-9A29C7CD00E9Q51193041-A54B774F-90EE-4075-B207-50038A790529Q51800946-212C8FB8-4DDD-49EE-A4C1-1A74ED32C02AQ55498681-BF29B701-AC98-41FD-912E-EBA4900CCA7DQ57155833-09FD0C3B-8101-48CD-8740-A0E98426CA7CQ57165548-3AAE6CA6-8051-4E02-B6BF-FEBD2FCD2F8CQ57491451-8AE5C519-9111-4C45-ACBE-B593D7917230Q58696771-479CAE26-A3B2-4A51-8D30-84E0E0FC6FC9Q58760475-315E81F7-F5D5-4E2A-BFBF-41688852CD28
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mitochondria in neurodegeneration.
@ast
Mitochondria in neurodegeneration.
@en
type
label
Mitochondria in neurodegeneration.
@ast
Mitochondria in neurodegeneration.
@en
prefLabel
Mitochondria in neurodegeneration.
@ast
Mitochondria in neurodegeneration.
@en
P2860
P1476
Mitochondria in neurodegeneration.
@en
P2093
Russell H Swerdlow
P2860
P304
P356
10.1007/978-94-007-2869-1_12
P407
P577
2012-01-01T00:00:00Z